Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|March 22, 1986
Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patientsR Badaró, E M Carvalho, H Rocha, et al.
The Journal of Clinical Investigation|December 1, 1985
Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasisE M Carvalho, R Badaró, S G Reed, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987
Parasite-specific humoral responses in different clinical forms of strongyloidiasisR Badaró, E M Carvalho, R B Santos, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1986
Isolation of Leishmania mexicana amazonensis from the bone marrow in a case of American visceral leishmaniasisA Barral, R Badaró, M Barral-Netto, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|August 10, 2000
HTLV-I associated myelopathy: clinical and epidemiological profileF L Figueirôa, A S Andrade Filho, E S Crvalho, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|June 15, 2007
Validation of criteria for nosocomial use of amikacin in Brazil with the Delphi techniqueL Noblat, M G G Oliveira, R Santos-Jesus, et al.
AIDS (London, England)|October 16, 2001
Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, BrazilC Brites, R Alencar, R Gusmão, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|January 1, 1989
Serum interferon activity of patients with leishmaniasisM Barral-Netto, R Diez, R Badaró, et al.
The Journal of Infectious Diseases|March 11, 1992
Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasiE M Carvalho, A Barral, D Pedral-Sampaio, et al.
The Journal of Infectious Diseases|February 1, 1993
Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania speciesW G Shreffler, J M Burns, R Badaró, et al.
Pageof 4